September 17, 2018

Share Start-ups

CellDom Wins $1.5M NIH Grant To Develop Single-Cell Analysis Platform


Celldom said today that it has received a $1.5 million Phase II Small Business Innovation Research grant from the National Institutes of Health. Celldom will use the award, administered by National Institute of General Medical Sciences, to advance the next generation of its high-throughput single cell analysis platform to analyze heterogeneity in cell populations for research and drug discovery.

The award, administered by National Institute of General Medical Sciences will be used by Celldom to advance the next generation of its high-throughput single cell analysis platform to analyze heterogeneity in cell populations for research and drug discovery.

This platform involves hardware for image-based, phenotypic analysis that adapt to standard high-resolution microscopes; single-use DNA-barcoded microfluidic chips containing thousands of “apartments” for isolating and perturbing single cells; and cloud-based software analytics.

In a statement by Celldom Cofounder, President, and CEO Zachary Forbes commented, “Heterogeneity within cell populations is emerging as an area of intense research interest, based on advances in understanding the … diversity of phenotypic, genetic, and biochemical responses of individual cells within complex cell populations,”

 

Read the full story here

 

[Originally posted by GenomeWeb — Sept 12, 2018]